DNDN and Prima have similar antibody based cancer treatment drugs but everything is not same.
Prima is relying on partners
DNDN would seek less partnership to maximize profits
DNDN is closer to probable accetance by FDA
Prima still has some distance to cover
DNDN's acceptance by FDA would definitely make things easier for Prima
DNDN and Prima have similar antibody based cancer treatment...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |